In order to study the relationship between RIPK1 expression levels and the aggressivity of diffuse gliomas, the TCGA-LGGGBM (The Cancer Genome Atlas-Low-Grade Glioma and Glioblastoma Multiforme) database was employed to evaluate 670 samples from patients. This evidence concerns the gene RIPK1 and central nervous system cancer.